Speakers

• Amy Rosenberg, Director, Division of Therapeutic Proteins, FDA
• Boris Gorovits, Director, Pharmacokinetics Pharmacodynamics & Metabolism, Pfizer
• Bruce Torbett, Co-Director, CFAR & Proteomics Expresssion Core, Scripps Research Institute
• Daniela Verthelyi, Chief, Laboratory of Immunology, FDA
• David Peritt, Scientific Director, Immunology, Hospira
• Don Zhong, Senior Scientist, Clinical Immunology, Amgen
• Eric Furfine, President, R&D, Eleven Biotherapeutics
• Holly Smith, Principal Research Scientist, Investigative Toxicology, Eli Lilly
• Jack Ragheb, Senior Regulatory Research Officer, CDER, FDA
• Jaymie Sawyer, Vice President, R&D, SQI Diagnostics
• Jo Goodman, Senior R&D Manager, Bioanalytical Sciences, Medimmune
• Joseph Bower, Executive Director, Immunochemistry, Covance
• Lawrence Tamarkin, CEO, Cytimmune
• Maria Barbosa, Senior Principal Scientist, Bioanalytical Sciences, Bristol-Myers Squibb
• Marina Dobrovolskaia, Senior Scientist, Nanotechnology Characterization Laboratory, NIH
• Mark McCamish, Global Head, Biopharmaceutical Development, Sandoz
• Martin Lechmann, Associate Director, DMPK, Merck Serono
• Martin Ullmann, Associate Director, Bioanalytical Research & Development, Bristol-Myers Squibb
• Peter Lollar, Professor of Pediatrics, Blood Disorder Center, Emory University
• Robert Massé, Vice President, Large Molecule Bioanalysis, Algorithme Pharma
• Roger Bosse, Global Product Leader, Alpha Technology, Perkin Elmer
• Swati Gupta, Principal Scientist, Bioanalytical Sciences, Allergan
• Thomas Lee, Scientific Investigator, Clinical Immunology, GlaxoSmithKline
• Yanhe Tong, Large Molecule Bioassays, Teva Pharmaceuticals